Full Length Research Paper
References
Bekers O, Uıjtendaal EV, Beıjnen JH, Bult A, Undrberg WJM (1991). Cyclodextrins in the pharmaceutical field. Drug Dev. Industrial Pharmacy17(11):1503-1549. |
|
Brewster ME, Loftsson T (2007). Cyclodextrins as pharmaceutical solubilizers. Advanced Drug Delivery Reviews 59:645-666. |
|
Connors KA, Mollica JA, (1966). Theoretical analysis of comparative studies of complex formation solubility, spectral and kinetic techniques. Journal of Pharmaceutical Sciences 55(8):772-780. |
|
Dhanaraju MD, Kumaran KS, Baskaran T, Moorthy MSR (1998). Enhancement of bioavailability of griseofulvin by its complexation with β-cyclodextrin. Drug Development and Industrial Pharmacy 24(6):583-587. |
|
Duchene D, Woussidjewe D (1990) The current state of β-cyclodextrin in pharmaceutics Acta pharmaceutica technologica 36(1):1-6. |
|
Elgindy N, Elkhodainy K, Molokhia A, Elzoghby A (2011). Lyophilized flutamide dispersions with polyols and amino acids: preparation and in vitro evaluation.Drug Development and Industrial Pharmacy 37(4):446-455. |
|
Fromming VK, Szejtli J (1994). Cyclodextrins in Pharmacy Dordrehcht, Kluwer Academic Publishers. |
|
Gabriel OKL, Yvonne TFT, Kok-Khiang P (2016). Enhancement of norfloxacin solubility via inclusion complexation with β-cyclodextrin and its derivative hydroxypropyl-β-cyclodextrin.Asian Journal of Pharmaceutical Sciences11:536-546. |
|
Higuchi T, Connors KA (1965). Phase solubility techniques. Advances in Analytical Chemistry and Instrumentation 4:117-149. |
|
Hirlekar RS, Sonawane SN, Kadam VJ (2009). Studies on the effect of water-soluble polymers on drug-cyclodextrin complex stability. American Association of Pharmaceutical Scientists 10(3):858-860. |
|
Jambhekar SS, Breen P (2016). Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discovery Today 21(2):356-362. |
|
Loftsson T, Duchene D (2007). Cyclodextrins and their pharmaceutical applications. International Journal of Pharmaceutics 329:1-11. |
|
Loftsson T, Friðrıksdottır H, Olafsdottır BJ (1991). Solubilization and stabilization of drugs through cyclodextrin complexation. American Association of Pharmaceutical Scientists 3(4):215-217. |
|
Loftsson T, Friðrıksdottır H, Thorısdottir S, Stefansson E (1994). The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. International Journal of Pharmaceutics 104:181-184. |
|
Loftsson T, Guðmundsdottir TK, Friðrıksdottır H (1996). The influence of water soluble polymers and pH on hydoxypropyl-β-cyclodextrin complexation of drugs. Drug Development and Industrial Pharmacy 22(5):401-405. |
|
Martindale (1993). the extra pharmacopoeia, 30th ed. Reynold J.E.F. ed. Pharmaceutical Press London, England P 208. |
|
Özdemir N, Erkin J (2012). Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Development and Industrial Pharmacy 38(3):331-340. |
|
Patel SG, Rajput SJ (2009) Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes American Association of Pharmaceutical Scientists 10(2):660-669. |
|
Polonisamy M, Khonam J (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile Drug Development and Industrial Pharmacy 37(4):373-386. |
|
Raja GV, Sekaran CB, Teja DW, Madhuri B, Jayasree B (2009). Simple spectrophotometric methods for the determination of sulfamethoxazole in pharmaceuticals using folinciocalteau and orcinol as reagents. Journal of Chemistry 6(2):357-360. |
|
Sharma N, Baldi A (2016). Exploring versatile applications of cyclodextrins: an overview. Drug Delivery. 23(3):729-747. |
|
Sinha VR, Anitha R, Ghosh S, Amita, Kumria R, Bhinge JR, Kumar M (2007). Physicochemical characterization and in vitro dissolution behaviour of celecoxib-β-cyclodextrin inclusion complexes. Acta Pharmaceutica 57:47-60. |
|
Szejtli J (1988). Cyclodextrin Technology, Dordrecht: Kluwer Academic Publishers. |
|
Szejtli J (1991a). Cyclodextrins in drug formulations: Part 1. Pharmaceutical Technology pp. 36-44. |
|
The United States Pharmacopeia (USP XXII) (1990). United States Pharmacopeial Convention Inc. 1260, Twinbrook Parkway Rockwille, MD 20852. |
|
Uekama K, Otagiri M (1987). Cyclodextrins in drug carrier systems. CRC 3(1):1-40. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0